Rating History for Aimmune Therapeutics (AIMT) by Cantor Fitzgerald
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/1/2020 | Charles Duncan | Downgrade | Neutral (Buy) |
35.00 (N/A) |
12.60 (34.49) |
173.73% | Details |
 |
|||||||
|
|||||||
|
|||||||
